Islam A, Molla A M, Ahmed M A, Yameen A, Thara R, Molla A, Issani Z, Hendricks K, Snyder J D
Department of Paediatrics, Aga Khan University Hospital, Karachi, Pakistan.
Arch Dis Child. 1994 Jul;71(1):19-23. doi: 10.1136/adc.71.1.19.
Rice based oral rehydration therapy (ORT) solutions have been shown to be superior to glucose oral rehydration salts (World Health Organisation (WHO) ORS) in reducing stool volume and duration of diarrhoea in children and adults. Rice based ORT has been used only sparingly in young infants, however, because of theoretical concerns about digestibility. A randomised controlled trial of rice based ORT (50 g rice and electrolytes identical to WHO ORS) and WHO ORS was carried out in 52 male infants less than 6 months old with moderately severe acute diarrhoea to evaluate efficacy and digestibility. Nineteen (70%) of 27 children who received rice based ORT and 18 (72%) of 25 children who received WHO ORS were treated successfully. The mean (SD) diarrhoeal stool output for the first 24 hours of treatment was significantly lower in the infants receiving the rice based ORT than in those receiving WHO ORS (101.0 (60.5) v 137.1 (74.6) g/kg). The stool output was also significantly less in the rice based ORT group in the second 24 hours. Infants in the rice based ORT group drank significantly less rehydration solution than infants in the WHO ORS group (mean (SD) 165.4 (77.4) v 217.9 (86.1) during the first 24 hours of treatment. There was no difference in the duration of diarrhoea between the groups. The volume of breast and formula feeding was similar in the two groups. No difference was seen in the frequency of finding reducing substances or acid pH in the stools of either group of children. The results suggest that rice based ORT is as effective as WHO ORS in infants with moderately severe diarrhoea and that rice based ORT is as well tolerated as WHO ORS in infants.
基于大米的口服补液疗法(ORT)溶液在减少儿童和成人腹泻的粪便量和持续时间方面已被证明优于葡萄糖口服补液盐(世界卫生组织(WHO)ORS)。然而,由于对消化性的理论担忧,基于大米的ORT在幼儿中使用较少。对52名6个月以下患有中度严重急性腹泻的男婴进行了一项基于大米的ORT(50克大米和与WHO ORS相同的电解质)和WHO ORS的随机对照试验,以评估疗效和消化性。接受基于大米的ORT的27名儿童中有19名(70%)和接受WHO ORS的25名儿童中有18名(72%)治疗成功。接受基于大米的ORT的婴儿在治疗的前24小时内的平均(标准差)腹泻粪便排出量显著低于接受WHO ORS的婴儿(101.0(60.5)对137.1(74.6)克/千克)。在第二个24小时内,基于大米的ORT组的粪便排出量也显著减少。基于大米的ORT组的婴儿比WHO ORS组的婴儿饮用的补液溶液显著更少(治疗的前24小时内平均(标准差)165.4(77.4)对217.9(86.1))。两组之间腹泻持续时间没有差异。两组中母乳喂养和配方奶喂养的量相似。两组儿童粪便中还原物质或酸性pH值的检出频率没有差异。结果表明,基于大米的ORT在患有中度严重腹泻的婴儿中与WHO ORS一样有效,并且基于大米的ORT在婴儿中与WHO ORS一样耐受良好。